Active — Not RecruitingNot Applicable

Evaluation of the Uterine Cavity in Perimenopausal Women.

Egypt50 participantsStarted 2025-02-01

Plain-language summary

Abnormal uterine bleeding (AUB) in perimenopausal women is a common yet poorly defined condition requiring accurate diagnosis. Hysteroscopy is the gold standard for evaluating intrauterine abnormalities, but 3D ultrasonography (3D US) has emerged as a non-invasive alternative.

Who can participate

Age range40 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: 40 -55 years. * Patients complaining of abnormal uterine bleeding not receiving hormonal treatment for the last three months or intrauterine device as it affects the endometrial thickness by ultrasound and the accuracy of the pathology. * Free from chronic medical diseases: renal, liver, chest and heart diseases. Exclusion Criteria: * Age less than 40 and more than 55 years. * Patients received hormonal treatment. * Patients with chronic diseases or have coagulopathy.

What they're measuring

The efficacy of 3 D ultrasound in diagnosis of uterine causes perimenopausal bleeding versus hysteroscopy

Timeframe: 3 months

Trial details

NCT IDNCT06888414

SponsorSuez University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-05-31

View on ClinicalTrials.gov More Abnormal Uterine Bleeding, Unspecified trials